BioSpace News Archive

Veeva Systems (NYSE: VEEV) today announced that Minaris Regenerative Medicine selected Veeva Vault QualityDocs and Veeva Vault Training to advance its global quality operations.

Glaukos Corporation today announced that its management is scheduled to participate in the William Blair 43 rd Annual Growth Stock Conference on Wednesday, June 7, 2023, at 10:40 a.m. CT in Chicago, IL.

Recent advancements in the Company’s pipeline, collaborations and operations, as well as financial results for the first quarter 2023, are summarised below. Exscientia will host a conference call Wednesday, May 24 at 1:30 p.m. BST / 8:30 a.m. EDT.

BeiGene today announced that the Company will participate in fireside chats at two upcoming investor conferences.

NurExone Biologic Inc. has released its financial results for the quarter ended March 31, 2023.

Endo International plc (OTC: ENDPQ) announced today that its subsidiary Endo Ventures Limited has executed an agreement with MAIA Pharmaceuticals, Inc. to distribute bivalirudin injection in a ready-to-use 250 mg/50 mL single-use vial in the U.S. Endo will commercialize the FDA-approved product through its Par Sterile Products business and expects to begin shipping in summer 2023.

Oculis Holding AG announces that its Head of Development, Dr. Bastian Dehmel, will be participating in the 2023 EuDES (European Dry Eye Society) Meeting in Munich, Germany on June 2-3, 2023.

Centessa Pharmaceuticals plc today announced that members of its management team will participate in the following investor conferences.

Innovative Cellular Therapeutics, Inc. (ICT) today announced the Company presented at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual meeting in Los Angeles, California. May 16-20, 2023.

Rani Therapeutics Holdings, Inc. today announced that it has appointed Kate McKinley as its Chief Business Officer.